Analysis of urine and other body fluids (AUBF) Clinical Microscopy Urine and other Body Fluids ◦Semen ◦Synovial Fluid ◦Serous Fluid ◦Amniotic Fluid ◦Feces ◦Vaginal Secretions Biologic Hazards ◦Potentially harmful to human ◦They may contain infectious agents such as bacteria, fungi, virus, or parasites. Infection Control ◦Procedures that will control and monitor infections occurring within the facility Standard Precaution ◦Standard set of guidelines to prevent the transmission of pathogens from exposure Means of transmission Unprotected host touch the patient, specimen or Contaminated object. Inhalation of dried aerosol particles circulating in air currents or attached to dust particles. Host inhales material from reservoir (aerosol droplet droplet from a patient). Ingestion of contaminated substance (food, water). From an animal or insect bite. Chain of Infection o Blood, Body Fluids, secretions, excretions, contaminated items 3. Mouth, Nose, and Eye Protection o Mucus membrane protection, sprays, aerosols 4. Gown 5. Patient Care Equipment o Dispose or sterilize as per protocol 6. Environmental Control o Cleaning and disinfection of surfaces 7. Linen o Prevent exposure when handling 8. Occupational Health and Blood-borne pathogens o No needle recapping 9. Patient Placement o Isolation if needed 10. Respiratory hygiene or Cough Etiquette Occupational Exposure to Blood-borne Pathogens Standard Monitored by OSHA (Occupational Safety and Health Administration) 1) All employees practice UP and SP 2) Employer provides gowns, coats, face and respiratory protection, gloves and laundry facilities for non-disposables 3) Provides sharps disposal, prohibits needle recapping 4) Prohibits eating, drinking, smoking, applying cosmetics in work area 5) Label all hazardous materials 6) Provide free immunization for HBV 7) Establish daily disinfectant protocol 8) Household bleach 1:10 9) Provide medical follow-up for workers exposed to bloodborne pathogens 10) Document regular employee safety training Safety hazards Radioactive Hazards • Radioisotopes in lab • Slight danger in lab • Symbol on doors • Radiographers wear badges to measure exposure • Pregnancy: avoid areas with this symbol Regulations and Guidelines UNIVERSAL PRECAUTIONS (UP) ◦1987, blood-borne pathogens (HIV, HBV) ◦Gloves and face shields with visibly bloody specimens BODY SUBSTANCE ISOLATION (BSI) ◦Puncture-resistant containers ◦All body fluids and moist body substances ◦Gloves at all times; did not stress hand washing Standard precaution 1. Hand Hygiene: hand washing + Alcohol-based antiseptic cleansers o Immediately after removing gloves 2. Gloves Electrical Hazards • Avoid water and fluid contact • Do not operate equipment with wet hands • Observe for frayed cords, overloads; report • Unplug and dry wet equipment • Equipment grounded with three-prong plugs Electrical Shock Accident ✔ Do not touch person ✔ Remove electrical source ✔ Turn off circuit breaker ✔ Unplug equipment ✔ Move equipment using wood or glass ❖Must be nonconductive Fire/Explosive Hazards JCAHO requires evacuation routes and detailed plan RACE ◦Rescue: anyone in danger ◦Alarm: activate ◦Contain: close affected area doors ◦Extinguish: if possible, or exit Physical Hazards • Running in rooms and hallways • Wet floors • Lifting heavy objects • Long hair not pulled back • Dangling jewelry • Open-toed shoes NFPA Hazardous material symbol Quality assessment (QA) Overall process of guaranteeing quality patient care Regulated throughout the total testing system. Composed of: 1. Quality Control – testing of control samples prior to testing. 2. Pre-examination variables – specimen collection, handling, and storage 3. Examination variables – reagent and test performance, instrument calibration and maintenance, personnel requirements and technical competence. 4. Post-examination variables – reporting of results and interpretation. Quality control -Internal QC -External QC -Electronic QC -Proficiency Testing (External Quality Assessment) Pre-examination variables “Pre-Analytical Phase” - Occurs before the actual testing of the specimen - Test Request Form - Patient preparation - Timing of collection - Manner of specimen collection - Handling and Storage Types of Fire Extinguisher Policy for handling specimens DO NOT ASSUME - DO NOT ASSUME any information about the specimen or patient. DO NOT RELABEL - Do NOT RELABEL an incorrectly labeled specimen. DO NOT DISCARD - DO NOT DISCARD the specimen until investigation is complete. Leave - Leave the specimen EXACTLY as you received it, put in the refrigerator for preservation until errors can be solved. Notify - Notify the floor/nursing station/doctor’s office of problem and why must it be corrected for analysis to continue. Identify - Identify problem on specimen requisition with date, time and your initials. Make - Make person responsible for specimen collection participate in solution of problem(s). Any action taken should be documented on the requisition slip. Report - Report all mislabeled specimens to the appropriate supervisor. Examination variables -“Analytical Phase” -Reagents and Type of Water (Deionized, distilled, or clinical laboratory reagent water) -Instrumentation and Equipment -Testing Procedures -Quality Control – monitor the accuracy, precision, and reliability of results • Ultrafiltrate of plasma, formed by the kidneys. • Reabsorption of water and filtered substances essential to body function converts 170,000 ml of filtered plasma to the average daily urine output of 1200ml. Urea • Primary organic component Product of protein and amino acid metabolism. • Product of protein and amino acid metabolism. Post-examination variables -“Post Analytical Phase” - Reporting of results -Delivery of results - Interpretation of results Errors in the laboratory PRE-EXAMINATION Patient misidentification Wrong test ordered Incorrect specimen collection Insufficient specimen volume Delayed transport of specimen Incorrect storage or preservation EXAMINATION Sample misidentification Erroneous instrument calibration Reagent deterioration Poor testing technique Instrument malfunction Interfering substances present Misinterpretation of quality control data POST EXAMINATION Patient misidentification Poor handwriting Transcription error Poor quality of instrument printer Failure to send report Failure to call critical values Inability to identify interfering substances URINALYSIS History -Early civilization (Egyptian hieroglyphs) where people are shown examining a bladder-shaped flask of urine. -Middle Ages: physicians concentrated their efforts on the art of Uroscopy. -Color charts have been developed that describes the significance of 20 different urine colors. -Chemical testing: “ant testing” and “taste testing” for glucose. Boiling urine for the presence of albumin. -17th century: development of microscope led to the microscopic examination of urine. Why is Urine tested? >Urine is readily available and easily collected. >Urine contains information, which can be obtained by inexpensive laboratory tests, about many of the body’s major metabolic functions. >“Urinalysis is the testing of urine with procedures commonly performed in an expeditious, reliable, accurate, safe, and costeffective manner”. - CLSI (Clinical and Laboratory Standards Institute) URINE Chloride • Primary inorganic component found in combination with sodium. • Found in combination with sodium. Creatinine • From creatine metabolism by muscles. Uric Acid • Nucleic acid breakdown in food and cells Sodium, Potassium Phosphate, Calcium Ammonia Normal Urine volume: 1200 – 1500ml (600 – 2000ml) OLIGURIA o Decrease in Urine Output o Infants: <1ml/kg/hr o Children: <0.5ml/kg/hr o Adults: <400ml/day ANURIA o Cessation of urine flow o May be a result of any serious damage to the kidneys or from a decrease in the flow of blood in the kidneys POLYURIA o Increase in Urine Output o Children: >2.5-3.0 ml/kg/hr o Adults: >2.5 L/day NOCTURIA o Increase in nocturnal excretion of urine o Diabetes mellitus o Diabetes insipidus DIABETES DIABETES MELLITUS o Decreased insulin or decreased function of insulin o Increased in glucose o Increased specific gravity of urine DIABETES INSIPIDUS o Decreased production or function of ADH (Adrenocorticotropic hormone/ vasopressin) o Decreased specific gravity of urine Urine collection CONTAINERS • Clean, dry, leak-proof • Disposable or washable containers • Wide mouthed to facilitate collections from female patients and a wide flat bottom to prevent overturning. • Clear material to allow determination of color and clarity • Recommended capacity: 50ml LABELS •Labeled properly with patient’s name and identification number •Date and time of collection •Additional information: age, sex, location of health care provider •Attached to the container not the lid. REQUISITIONS • Manual or Computerized • Accompany the specimens delivered to the laboratory • Method of collection or type of specimen • Time the specimen is received in the laboratory. Specimen rejection 1. Specimens in unlabeled containers 2. Non-matching labels and requisition forms 3. Specimens contaminated with feces or toilet paper 4. Containers with contaminated exteriors 5. Specimens of insufficient quantity 6. Specimens that have been improperly transported. NOTE: Never discard a specimen before checking with a supervisor. Specimen integrity ◦ Urine specimens should be delivered to the laboratory promptly and tested within 2 hours ◦ If specimen cannot be delivered and tested within 2 hours, it should be refrigerated or have an appropriate chemical preservative ◦ Refrigeration at 2-8 C ◦ Chemical preservatives: Boric Acid, Formalin, Sodium fluoride NOTE: Specimens must be returned to room temperature before chemical testing by reagent strip. Types of Specimen Purpose Routine Screening Routine screening, Pregnancy tests, Orthostatic proteinuria 24-hour or timed Quantitative chemical test Catherized Bacterial culture Mid stream clean-catch Routine screening, bacterial culture Suprapubic Aspiratiton Bladder urine for bacterial culture, cytology Three-glass collection Prostatic infection Type of Specimen Random First morning Drug specimen collection Urine collection is the most vulnerable part of drug-testing program. Chain of Custody (COC) ◦ the process that provides documentation of proper sample identification from the time of collection to the receipt of laboratory results. Volume: 30-45 ml Collections: ◦ Witnessed – same-gender collector will observe the collection ◦ Unwitnessed Urine analysis Physical examination >Urine color, clarity, specific gravity Chemical examination >Different chemical composition of urine >Glucose >Protein Microscopic examination >Detect and identify insoluble materials >Cells >Urinary Sediments